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Three-dimensional tissue models, ranging from spheroids to ex vivo samples of larger xenografts or even human 
tissues, are currently under extensive development to provide more biologically relevant preclinical models for 
personalized medicine and biopharmaceutical research1–3. The field of microfluidics has so far provided a large 
number of technical solutions to facilitate the trapping, culture and analysis of these tissues2, 4–6. An increasingly 
popular class of device to achieve this is the microfluidic sample trap (MST). As it is defined herein, MSTs are 
any device that allow to individually trap micrometre to millimetre-scale cell and tissue samples in a channel 
recess, hanging drop, or small chamber adjacent to a main channel where samples circulate in a carrier fluid 
(Fig. 1). They can be used to load samples or simply grow them within the trap from injected cell suspensions as 
in spheroid synthesis. The trapping mechanisms to load samples within the device vary depending on the design 
(Fig. 1A) and can combine many mechanisms studied by different authors, such as i) sedimentation trapping, 
where waiting for the tissue to settle into an extrusion from a channel traps it7–10; ii) resistive trapping, which 
exploits preferential flow to guide samples into traps11–16; iii) inertial trapping, which uses focusing flows or sharp 
turns to trap samples in channel recesses17–19; iv) dielectrophoretic trapping, where the difference in permittivity 
between the fluid and tissue is exploited to trap it in an electric field20, 21; v) and open-microfluidic channel net-
works, which create hanging droplets in which samples are trapped or synthesized22, 23.
In most designs, the trap itself allows tissues to be somewhat shielded from potentially damaging shear stress 
because the fluid velocity in it is only a fraction of what it is in the adjacent channel8. Although reflow of channel 
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fluid in the trap is minimal, the small scale of the device allows the diffusion of nutrients and other species to 
occur quickly from the channel to the trap (and, conversely, diffusion of waste from the trap to the channel) 
relative to culture times. The relatively small design dimensions also allow to put a large number of traps (>100) 
within the same channel9. Additionally, if the device is made with a material porous to air (e.g. PDMS), it allows 
oxygen to be supplied throughout the experiment without requiring medium perfusion; while supplying other 
nutrients and purging waste require perfusion or periodic medium change24, 25. Finally, making the device with a 
transparent material (e.g. glass, PDMS) allows observation and analysis of samples in the device by different types 
of microscopy and wide field imaging26. All of these points show how MSTs are particularly effective at sustaining, 
treating and analysing large numbers of samples simultaneously.
Furthermore, even without perfusion, the viability of in vitro or ex vivo 3D tissue model samples has been 
shown not to be affected for sufficiently small tissues and with periodic medium change10, 24. The present 
study focuses on 3D tissue model sample culture in the absence of perfusion for three reasons: (1) studying 
non-perfused devices provides a worst-case evaluation of tissue viability; (2) integrating flow pumps to per-
fuse hundreds of samples simultaneously inside an incubator can be a barrier to adopting the technology by 
non-specialized users; (3) controlling small devices with large external pumps is counterintuitive to the miniatur-
ization process. In the case of devices that are designed to not require perfusion, convection-based transport and 
metabolite diffusion are decoupled because they happen on different timescales. Convective effects occur briefly 
during loading, unloading and medium changes, and diffusive effects occur throughout the experiment.
Although designs and their trapping mechanisms vary, the simplest is a cubic extrusion from a channel or a 
well as Fig. 1B shows in three dimensions (a) and two dimensions (b). Figure 1B shows a cross-section of such 
a simple sedimentation trap made with PDMS10 viewed from the top (c) and the side (d). Figure 1A shows the 
basics of this device’s operation in its most fundamental form. In all cases, the trapping mechanism is caused by 
volume forces (FV) acting on samples, yielding an effective force towards the trap. Loading 3D tissue model sam-
ples into the device is done through the channel by applying a flow rate at the entrance or suctioning at the outlet 
and waiting some time to let the samples enter the trap. With a non-perfused design, as is the case in this analysis, 
it is necessary to change the medium periodically to replenish nutrients and evacuate sample excretions in the 
channel as it is cultured. All these aspects of device operation (trapping times, flow rates and medium replenish-
ment) must be tuned to ensure that the device itself does not bias tissue viability.
This article aims to simplify MST design by studying different physical constraints (settling times, shear stress, 
lift forces, nutrient availability) that depend on device design and affect its operation (applied flow rates and 
medium replenishment frequency). To do so, analytical models are developed and compared to numerical mod-
els solved with a combination of the finite element method and broad parametric sweeps over all main design 
Figure 1. Basic MST designs: (A) MST operation with schematics of different trapping mechanisms: resistive, 
dielectrophoretic, inertial and sedimentation trapping; blue axis is parallel to gravity. The picture of the western 
hemisphere of earth on a transparent background was solely created by NASA and is in the public domain in 
the United States. (B) Simplified 3D (a) and 2D (b) MST design with a top (c) and side (d) view of a PDMS chip 
with these features; scale bar is 1000 μm.
www.nature.com/scientificreports/
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variables. The hydrodynamic models study non-adherent sample trapping and ejection dynamics for samples of 
similar sizes to the trap. The various diffusion-reaction models use experimental data on metabolite transport 
kinetics compiled from relevant cell-based studies. With these parametric sweeps, the results can be applied to 
many devices because the concept of a channel containing extrusions or wells that permit the trapping, culture, 
analysis, and release of single cells, spheroids and tissues has been applied in diverse scales. We demonstrate how 
and why these devices work and how to design them to achieve optimal operation for specific applications.
??????????????? ??????????
The finite element method (FEM) is used in this work to model the device and simulate the effect of device design 
on device operation and tissue viability. The 3D geometry as shown in Fig. 1B was drawn, meshed, and different 
effects were solved numerically with COMSOL Multiphysics® v.5.2 (COMSOL AB, Stockholm, Sweden) run on 
a calculation server with dual Intel Xeon E5-2695V2 (2.4 GHz 12 core CPU) and 128 GB of RAM (Cyberlogic, 
Montreal, Canada). The software was chosen for its ability to easily do and analyse parametric sweeps with the 
built-in tools. COMSOL’s built-in probe functions, reactive force operators and the customizable parametric 
sweeps with stop conditions were key tools to produce the results.
???????????????????????????????? There are three classes of design parameters in this study: parameters 
that affect device operation, parameters that do not affect device operation and tissue parameters.
Device operation, meaning imposing a flow rate in the channel (to trap and release tissues or change channel 
medium) and refreshing metabolite concentration in the channel (to keep tissues alive), is affected by the follow-
ing design parameters shown in Fig. 2B: well parameters as in well height (h) and well cross-section (w × w); and 
channel parameters as in channel length (distance between two traps) (L), channel cross-section (A) and channel 
volume (V). The available medium volume per trap VM is approximately equal to the channel volume V if ?L w.
The design parameter that does not affect device operation is PDMS thickness which is set at 3 mm, a value 
typically found in standard applications and not critical to derive most results.
Figure 2. MST simulation methodology: (A) Sample traps operation schematic: (1) trapping of a tissue, 
spheroid or cell suspensions using any trapping mechanism (typically with volume forces), (2) culture, growth, 
treatment and in-vitro analysis of the tissues, and (3) release, ejection or collection of the samples from the 
traps for external analysis (e.g. flow cytometry). (B) Characteristic dimensions of the device with: L the inter-
well separation, A the channel cross-section, V the available medium volume per well, d the tissue diameter 
(assuming a spherical tissue), w the well size (assuming a square well) and h the well depth. (C) Degrees of 
freedom for designing the device: (a) scaling the device up and down while keeping the tissue size constant 
compared to the well size, (b) scaling the tissue size while keeping all other dimensions constant, (c) scaling 
the trap height while keeping all other dimensions constant, and (d) scaling the available medium volume per 
well while keeping all other dimensions constant (inset shows the 1D simplification of the device for analysing 
diffusion of metabolites).
www.nature.com/scientificreports/
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The variability of tissue uptake parameters (tissue cellular density – inverse of cell size –, uptake rate and 
Michaelis-Menten constant) in literature is presented in Table 1 for two nutrients essential to metabolism: glucose 
and oxygen. The typical parameter values are taken from EMT6/Ro which are a fully characterized cell type for 
uptake and diffusion parameters. These parameters are pertinent but not essential for a diffusion analysis because 
they can be estimated in a worst-case approximation. For a fluid dynamics analysis, the only tissue parameter that 
is required is tissue diameter d, as shown in Fig. 2B, which is known by the type of tissue being trapped.
For diffusion parameters, oxygen diffuses through PDMS easier than through water27, 28 as the diffusion con-
stant of PDMS (ranging from 3.25 × 10−5 cm2/s27 to 7.88 × 10−5 cm2/s29) is higher than that of water (ranging 
from 1.80 × 10−5 cm2/s at 20 °C to 2.78 × 10−5 cm2/s at 40 °C30). Thus, a simplified diffusion-reaction model of an 
oxygen consuming spherical tissue in an infinite sphere of water provides a worst-case analysis of oxygen supplied 
through the gas-permeable PDMS walls of the device. This simplified model approximates the maximum viable 
tissue diameter (dmax) to prevent anoxia10:
ρ
μ=
⎛
⎝
⎜⎜⎜⎜
+
⎞
⎠
⎟⎟⎟⎟
≈
− −
−
d
q D c D c
2 3 1
2
1 500 m,
(1)cell T T sat M M sat
max
max
1
where D is the diffusion constant in the medium (M) or tissue (T), csat is the saturation constant, qmax is the max-
imum uptake rate and ρcell is the tissue cellular density in cells/μL. The value of dmax sets the maximum value for 
tissue size in the numerical simulations and parametric sweeps.
To study the effect of design parameters that affect device operation, they must be modified independently 
with broad parametric sweeps in the numerical models that lead to as many degrees of freedom of the analysis 
as there are design parameters. These degrees of freedom must be minimized to a set of core “design variables” 
(DV) to reduce redundancies. Figure 2C shows the DVs circumscribed in this article. The primary DV is scaling 
the device down from its maximum size determined by dmax (Fig. 2C(a)), which adjusts the device for applica-
tions going from single-cell trapping to millimetre-scale 3D tissue model sample trapping. The secondary DV is 
varying tissue size within a trap of given dimensions (Fig. 2C(b)), which gives insight on sample behaviour that 
have a deviation from average dimensions since tissues are never all uniform in size. The tertiary DV is varying 
trap depth (Fig. 2C(c)), which describes sample behaviour based on the trap shape; a tissue in an elongated trap 
will behave differently from a tissue in a shallow trap. The final DV that is used solely for diffusion models is 
the inter-well separation (Fig. 2C(d)) which governs how densely multiple traps can be juxtaposed. The broad 
parametric sweeps performed on the four DVs lead to four series of over a thousand simulations each that have 
been graphically represented in Fig. 3C through Fig. 3E and Fig. 4C. A small sample of one such series for the 
secondary DV is provided (see Supplementary video).
????????????????? Tissue trapping encompasses the dynamics of tissues settling in a liquid-filled trap due to a 
volume force FV; with buoyancy, this force is ρ ρ= −F gV( )V T M T eff . With ρ the density of the tissue (T) and 
medium (M), V the volume and geff the effective acceleration. In this study, gravity is assumed as the driving force 
FV but could be replaced by any of the volume forces shown in Fig. 1A.
Sedimentation of a solid spherical tissue of diameter d in a reservoir with dimensions comparable to its diam-
eter is more complex than that of a sphere falling in an infinite medium. The drag force on a settling sphere 
increases with the ratio of the sphere cross-section on the reservoir cross-section in the direction of sedimenta-
tion31. To model this effect, the reference frame is changed to that of the settling sphere32. A sphere settling in a 
long prism (Fig. 3A inset) thus becomes an immobile sphere in a moving long prism with a moving wall bound-
ary condition. The reactive force on the tissue (i.e. drag force in this referential) is found numerically with the 
reacf operator built into COMSOL. In the case of computational fluid dynamics, this operator evaluates the net 
vector force of flow on boundary nodes. The reactive force is found by summing this operator over all boundary 
nodes of the tissue.
With a parametric sweep on the moving wall velocity, the numerically evaluated drag force must be equal to 
the driving force on the sphere at which point the moving wall velocity is considered equal to the tissue settling 
speed. This method results in finding the settling speed vset comparable to equation (3) and shown in Fig. 3A.
Tissue uptake parameters Minimum Maximum Typical
Tissue cellular density ρcell (cell/μL) 2.1 × 105 47 4.0 × 105 48 2.8 × 105
Maximum cellular uptake 
rate qmax (mol/cells · s)
Glucose 2.7 × 10−18 49 2.5 × 10−16 50 3.9 × 10−17
Oxygen 1.7 × 10−18 51 7.0 × 10−16 52 7.4 × 10−17
Michaelis-Menten constant 
kM (mM)
Glucose 4 × 10−2 47 6 × 10−2 49 4 × 10−2
Oxygen 4.6 × 10−3 50 6.9 × 10−3 53 4.63 × 10−3
Diffusion constant of O2 Dx 
(cm2/s)
Medium 2 × 10−5 46 3.35 × 10−5 52 2.44 × 10−5
Tissue 9.5 × 10−6 29 3.6 × 10−5 54 1.85 × 10−5
Saturation concentration of 
O2 cx-sat (mM)
Medium — — 0.2110
Tissue — — 1.0229, 55
Table 1. Tissue uptake parameters found in literature for various cell types and the typical value used in the 
models.
www.nature.com/scientificreports/
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?????? ?? ???? ???????? ??????????? As the results in Fig. 3B show, when a flow rate is applied in the chan-
nel, the tissue is pinned upstream by fluid recirculation within the trap. Thus, fluid dynamics effects are modelled 
Figure 3. Hydrodynamic numerical results (A) Settling time as a function of the ratio of tissue diameter d 
over trap width w (as pictured in the inset) for two well cross-sections (cylindrical and square) compared to the 
analytical approximation by Haberman et al.32. Settling distance over a height of w (cubic well) for tissues 2% 
heavier than water. (B) Streamlines (red lines), flow velocity colour map (mm/s) in the well around the tissue, 
and shear stress greyscale map (Pa) on the tissue with the net resulting force of the flow on the tissue (red arrow) 
for a flow rate generating tissue lift Qlift (a) and generating damaging shear stresses Qshear (b). Phase diagram 
representation of critical flow rates for tissue ejection Qlift and tissue shearing Qshear for (C) varying trap width 
(or device scale) with a constant ratio d/w = 0.5 and w = h (result of ~5,800 simulations), (D) varying diameter 
over trap width ratios with w = h = 0.5 mm (result of ~4,300 simulations) and (E) varying trap height with a 
constant ratio d/w = 0.5 and w = 0.5 mm (result of ~1250 simulations).
Figure 4. Spatial distribution of metabolites for VM/VT ≈ 300, d = 375 μm and w = 750 μm (A) Colour mapping 
of the distribution of (a) oxygen in a full PDMS device, (b) oxygen in a PDMS device set on a glass slide, 
(c) glucose after 3 days, and (d) glucose after 87 hours; all normalized by the saturation concentration. (B) 
Distribution of various nutrients through the tissue and their associated Michaelis-Menten constants. (C) Time 
in hours before the minimum concentration of glucose in the tissue dips under the Michaelis-Menten constant, 
indicating a possibility in affecting cell metabolism as a function of the ratio of available volume per well on 
tissue volume (result of ~4,000 simulations). (D) Schematic of different available medium volume per well (VM) 
on tissue volume (VT) ratios.
www.nature.com/scientificreports/
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with the spherical tissue upstream in the trap. This phenomenon has been studied for smaller particles in similar 
geometries8. Similar experimental observations were made using Polyethylene Microspheres in sedimentation 
traps such as those of Astolfi et al.10 (see Supplementary video). Additionally, since the tissue is pinned upstream, 
as the tissue lifts it is increasingly driven by vertical flow, thus increasing lift. This means that once the tissue takes 
off, it is very quickly ejected from the trap. These results are summarized in Fig. 3B through Fig. 3E.
For the numerical models, except when specified otherwise, walls are set with no slip (Dirichlet) boundary 
conditions on fluid velocity. The device is operated with a constant flow (Q) at the inlet and no stress (p = 0 Pa) 
at the outlet.
Critical flow rates to generate potentially damaging shear stress (Qshear). The maximum value of the numerically 
solved shear rate over the surface of the tissue, multiplied by the fluid’s dynamic viscosity, gives the maximum 
shear stress on the tissue. To find the critical maximum flow (Qshear), the inlet flow rate (Q) is swept up until the 
maximum value of the shear stress (τ) exceeds physiological levels of 1 Pa33–35. Above this conservative value, cells 
are considered damaged as shear stress affects cellular phenotype36 and may induce apoptosis37, inhibit prolifera-
tion38 or remove adherent cells34. This method results in numerically finding the critical maximum flow rate that 
induces damaging shear (Qshear).
Critical flow rates to lift tissues (Qlift). With large enough channels or high enough flow rates, Reynolds numbers 
can climb to reach transitional flow regimes which may generate lift forces that eject tissues. If the critical flow 
rates to reach those regimes are of the same order as loading flow rates, trapping stability is affected negatively. In 
other circumstances, this lift effect can be desirable and exploited to intentionally eject tissues from their traps. 
Numerically evaluating the net vertical force of the fluid onto the tissue resting at the bottom of the trap gives the 
lift force experienced by the tissue. Similar to finding the drag force for settling tissues, using the reaction force 
operator built into COMSOL gives the net vector force on the tissue. The vertical component gives the lift force, 
the longitudinal component gives the pinning force and due to symmetry the transversal component is null. If 
the lift force exceeds the net force pulling the tissue down (gravitational pull and buoyancy), then the associated 
flow rate is marked as being Qlift. This method results in finding the minimum critical lift flow rate (Qlift) because 
it assumes tissues do not adhere to the surface. Partially adherent tissues require higher lift flow rates.
???????????? ?????????????????????????? As there is no perfusion, the tissue can settle randomly at the 
bottom of the trap. Thus, as it is the worst-case scenario for metabolite diffusion, numerical diffusion simulations 
are done with the sample in the middle (DO2 in PDMS is greater than in water) and at the bottom (furthest from 
the channel) of the trap.
To model diffusive effects, except when specified, all walls are set with no-flux (Neumann) boundary con-
ditions. All interface boundaries (Air/PDMS, PDMS/Medium and Medium/Tissue) are set with a continuity 
condition on metabolite concentration normalized by the saturation concentration in the material, and on dif-
fusive flow through these interfaces. Boundaries that allow for medium to flow in and out (inlets and outlets) 
are set with a periodic boundary condition to account for the presence of other traps. The initial concentra-
tions of metabolites are set to the experimental values (11 mM)10. Finally, the tissue consumes metabolite with a 
Michaelis-Menten kinetics39,
=
+
x x
x
q c t q c t
c t k
( ( , )) ( , )
( , ) (2)M
max
where the values of the Michaelis-Menten constant (kM) and the maximum uptake rate (qmax) are shown in 
Table 1.
Diffusion of continuously replenished metabolites. Continuously replenished metabolites (i.e. oxygen) are provi-
sioned through all PDMS surfaces exposed to air. Setting a constant air concentration boundary condition on all 
these surfaces models the presence of continuously replenished metabolites. Setting a no-flux boundary condi-
tion on the surface right under the trap models the case where the device is bonded onto a glass slide. Although 
the maximum tissue diameter may not be reached within certain device geometries, the numerical value of the 
minimum oxygen concentration within the tissue gives an idea on the effect of device design on diffusion of con-
tinuously provisioned metabolites (Fig. 4A,B).
Diffusion of finite metabolites. Finite metabolites, those that can be depleted in a medium (i.e. glucose), 
are strictly provisioned through the channel and require a medium change to be replenished. Running a 
time-dependent solver on a tissue consuming only the initially available nutrients in the medium models the 
diffusion of finite metabolites. The time-dependent solver is stopped when the minimum concentration of nutri-
ents in the tissue reaches the Michaelis-Menten constant (kM), the threshold commonly accepted under which 
concentration limits uptake kinetics39. At that concentration, the uptake rate of cells is reduced to half of that of 
cells with an abundance of nutrient (qmax with a zero order kinetic). The corresponding time is then plotted as a 
function of available medium volume per trap (VM) per tissue volume (VT) in Fig. 4C.
Numerical Models and Results
In this section, the Finite Element Method is used to solve the numerical simulations defined previously to 
describe different properties of device operation and design. The results for tissue trapping, fluid mechanics and 
nutrient diffusion are presented and compared to expected analytical results when available.
www.nature.com/scientificreports/
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???? ??????????????????? The case of a sphere settling in an infinitely long cylindrical reservoir of diameter 
w was solved analytically and approximated numerically with the following equation32 and is shown in Fig. 3A as 
a function of d/w.
ρ ρ
η
≈
− .
− . + . − . + .
⋅
−
(3)
v d w d w
d w d w d w d w
g d( / ) 1 0 76( / )
1 2 1( / ) 2 1( / ) 1 7( / ) 0 73( / )
1
18set
T M
eff
5
3 5 6
2
The settling time of tissues in gravitational traps is derived by dividing the length over which a tissue settles (h) 
by the settling speed of equation (3) and constitutes an upper bound on the experimental sedimentation time in 
a cubic trap. Bottom wall effects40 are neglected. The numerical results were derived for a settling length and trap 
size of w = h = 500 μm. As settling slowdown due to sample confinement is only a function of d/w, the shape of the 
curve is not affected by the trap size. It will, however, increase or decrease settling times inversely proportionally 
to the change (t ∝ w−1). Decreasing the trap size by a factor of 10 will increase settling time by a factor of 10.
Figure 3A gives the complete information on settling times in gravitational traps. As expected, very small 
samples are exceedingly difficult to sediment due to their low weight and very large samples are exceedingly 
difficult to sediment due to increasing drag forces. This result shows that a square trap of a dimension between 
1.4 and 3.3 times the tissue diameter (0.3 < d/w < 0.7) will minimize settling times. With this result, all further 
numerical simulations that do not require to vary tissue dimension are optimized with an average tissue to trap 
size ratio of d/w = 0.5.
??????? ?????????? ????????? ???????? Figure 3C through Fig. 3E show the viable design and operating 
windows graphically. First, operating regions where tissues are subjected to damaging shear are highlighted in 
red. Second, optimal operating regions where tissues are removed from the device before being damaged are 
highlighted in orange. Third, operating regions where tissues remain in the device and aren’t damaged by shear 
are highlighted in green. A proper device usage ensures that shear stresses never exceed critical values in the trap. 
Therefore, assuming a non-adherent surface, an optimal design guarantees the tissue is ejected from the trap 
before these shear stresses are reached.
Minimum trap size. MST devices should be designed so that critical shear stresses are never reached within 
operating conditions. In effect, this means that the critical flow required to shear and damage tissues (Qshear) must 
be higher than the critical flow required to eject tissues from the device (Qlift). However, as the device is scaled 
down to smaller dimensions, Qshear ∝ w3 drops faster than ∝Q d wlift
2, as per equation (4). This means that there 
is a minimum trap width wmin under which tissues are potentially damaged by flow shear stress before being 
ejected from the device. Assuming a cubic trap with h = w and a tissue to trap size ratio of d/w = 0.5, equation (5) 
describes this.
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wmin is considered the minimum trap size under which shear stress reaches 1 Pa before the tissue is lifted and is 
12 μm with Table 1. With a tissue to trap size ratio of d/w = 0.5, wmin can be simulated numerically by scaling the 
entire device down from the maximum tissue diameter of dmax = 500 μm. Finding the crossing point of the critical 
flow rate for lift and the critical flow rate for shear stress as a function of the well width w gives that minimum 
trap size.
Figure 3C shows the numerical results of the simulations where the Haberman approximation is bounded by 
the square and cylindrical well results. These results consider a tissue of 1.02 g/cm3 density10 and are of the same 
order as the result in equation (5). A lighter or less compact tissue will result in a lower critical lift flow rate and 
minimum trap size. Conversely, a denser tissue will result in a higher minimum trap size. Although the results 
suggest to refrain from designing traps under the minimum trap size, if proper care is taken to limit flow in the 
device through external means, it is possible to make a device under the minimum trap size. The only drawback 
would be that tissues would not be extractable by applying flow and would require to dismantle the device or to 
design a separate extracting mechanism.
Tissue size variance. As all tissues are not exactly the same size, this section provides an analysis of tissue behav-
iour within the device for varying tissue dimensions. Similar to the previous section, ensuring that the device 
operates in a regime where damaging shear is impossible (Qshear > Qlift) will lead to a more robust design. As the 
trapped tissue dimension changes within the device, the ease of shearing and ejecting it also changes.
Figure 3D highlights the design viability window in which the tissue is not subjected to damaging shear 
stresses but can still be ejected. Trapping tissues in too big (w > d/0.3) or too small (w < d/0.9) a device will lead 
to potentially damaging shear stresses before tissue ejection. This also shows that the d/w = 0.5 ratio proposed 
by settling times falls near the middle of this design viability window and it confirms that using it for numerical 
simulations does not lead to poor designs.
www.nature.com/scientificreports/
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Trap aspect ratio. The shape and aspect ratio of the trap can also be tuned to fit specific applications. These 
simulations aim to study the effect of changing the well depth on the viability of tissues within a specific design. 
Figure 3E shows that increasing well height systematically impedes damaging shear stress. The reason for that can 
be seen from the colour mapping of Fig. 3B: the magnitude of fluid velocity in the trap decreases exponentially 
with depth. As the trap is elongated (increasing height), tissues become exponentially harder to shear and eject. 
However, as the trap is shortened (reducing height), tissues are more affected by flow in the channel and are easier 
to shear and eject. Figure 3E also has an inversion around h ≈ 1.2 w which shows that the optimal trap shape is a 
cube (or a trap with a height of similar scale to its cross-section).
???? ?????????? ??????????? The main purpose of MST devices is to provide miniaturized culture plat-
forms for assays involving 3D tissue models. Therefore, replenishing the device medium periodically is necessary 
to sustain and maintain high viability of 3D tissue model samples. Modelling how nutrients are consumed and 
diffuse in and around the tissue leads to a better understanding of these replenishment times and ensures that 
device design affects tissue viability the least.
The numerical simulations aim to estimate how long tissues can remain trapped without replenishing the 
medium and without affecting cell metabolism. For this, we focus on characterizing two nutrients essential to 
cell metabolism found in most culture media: oxygen and glucose. Since a Michaelis-Menten uptake kinet-
ics is considered per equation (2), we set the nutrient threshold concentration to affect cell metabolism as the 
Michaelis-Menten constant kM. Although there are complex mathematical models of cell proliferation and 
death41, this threshold on cell metabolism is a subset of such models that leads to conservative replenishment 
times.
Metabolite spatial distribution. Figure 4A,B respectively show the distribution of nutrients through the device in 
2D and through the tissue in 1D. This provides insight on diffusion mechanism and on the actual position in the 
tissue where the minimum nutrient concentration is. For the purpose of this section, a slightly larger device has 
been chosen, with d = 375 μm and w = 750 μm, to better see the effect of nutrient depletion and to demonstrate 
the worst-case scenario.
Figure 4A(a,b) shows that the bottom of the tissue has more oxygen due to oxygen diffusing easier through 
PDMS than through water. However, oxygen distribution in PDMS is nearly halved in the case of a device with 
a glass bottom. The non-porous glass slides upon which users sometimes set their devices have a dramatic effect 
on oxygen supply to biological samples. If a device relies on the porosity of the material used to supply oxygen, 
setting it on or bonding it to a glass slide is counter-intuitive.
The two-dimensional representation of nutrient distribution in Fig. 4A(c,d) shows that the bottom of the trap, 
or the side further from the channel, has less glucose. The shape of the trap does not affect much other than the 
position of the minimum nutrient concentration in the case of nutrients supplied exclusively through the channel 
medium as Fig. 4B shows.
Medium replenishment window. Under a certain channel length Lmax, channel shape does not significantly 
affect metabolite transport to the tissue. The nearly uniform glucose concentration of Fig. 4A(c) shows that dif-
fusion occurs in similar or smaller timescales as nutrient uptake until glucose concentration reaches kM as seen 
in Fig. 4A(d). Figure 4C shows that increasing tissue volume hastens glucose consumption, reducing the time 
required to affect cell metabolism t. Similarly, increasing the available medium per tissue increases the available 
glucose, increasing the time required to affect metabolism t. The linear regression of Fig. 4C follows the expected 
trend of equation (6) which was derived in previous work10 using the 1D simplification in Fig. 2B(c) inset for a 
regime that is not diffusion-limited.
ρ
= +t a c
q
V
V
b
(6)cell
M
T
0
max
where c0 is the initial metabolite concentration, VM is the available medium volume per tissue, VT is the volume of 
consuming tissue, qmaxρcell is the maximum metabolite uptake in mol/m3s as shown in Table 1, and a and b are 
lumped proportionality constants that account for design geometry. For equation (6) to be valid, the longest 
dimension of the channel needs to be small enough (equation (7)) to stay out of a diffusion-limited regime. This 
is derived from a zero order Damköhler number Da0 = tdiff/tup using the total nutrient uptake time 
ρ=t c V q V/up M cell T0 max  and the total nutrient diffusion time tdiff = L
2/8DM where Da0 < 1 to remain out of a 
diffusion-limited regime. With a target VM/VT = 100 (or t = 24 h), the threshold value Lmax is approximated to 
6.41 mm with the parameters of Table 1.
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To use Fig. 4C, the desired maximum replenishment time and maximum tissue volume are required; in other 
words, the experimental frequency of medium replenishment and the largest trapped tissue samples. With the 
figure, medium replenishment time gives the target VM/VT ratio and the largest expected VT returns the required 
medium volume. Figure 4D shows different VM/VT ratios for different trap densities and tissue sizes. In practice, 
two things must be considered: (1) as Fig. 4B shows, the region where metabolite concentration starts to affect 
metabolism is a small fraction of the tissue and (2) metabolite change takes some time to actually affect cell viabil-
ity. This results in a practical wait time that can be significantly longer than the time in Fig. 4C without affecting 
tissue viability.
www.nature.com/scientificreports/
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??????????
The previous numerical results provide a thorough example of how MSTs can be optimally designed and oper-
ated. This section compiles these results and summarizes the proposed design constraints of sample traps depend-
ing on the known sample characteristics. Table 2 summarizes the main design parameters as enumerated in the 
method section and shown in Fig. 2B.
We conclude that the optimal dimensions of a trap are a base of 2d × 2d and a height slightly lower than 2d; in 
other words, a cube of side 2d. Although these dimensions are around 2d ≈ w ≈ h, this would potentially allow 
several tissues to be trapped within the same trap unless manually loaded. To ensure that only a single sample is 
allowed per cubic trap, the dimensions of the trap need to be slightly smaller (w ≤ 1.4d) than what is recom-
mended in Table 2. Also, Fig. 3E shows that making a trap shallower or deeper than 0.9w reduces the operating 
window in which tissues are ejected before being sheared. This leads to a higher minimum trap size and more 
stringent operating windows for tissues of varying dimensions when ≠ .h w0 9  compared to Fig. 3C,D respec-
tively. Additionally, if the trap is too elongated, it will allow multiple samples to be trapped on top of each other 
regardless of trap dimensions, thus requiring user input to ensure single sample trapping. Opting for cubic or 
shallower traps solves this issue. Finally, since flow recirculation affects samples higher in the trap more strongly 
than samples at the bottom, it is possible to design traps that theoretically allow several samples but still trap sin-
gle samples.
With a d/w ratio of 0.5 and d = 250 μm set at half the maximum tissue diameter, Table 3 emphasizes which 
aspects of device operation are affected by sample density. For the case of ejection flow rates, the Supplementary 
video concords with expected flow rate values (re-evaluated precisely for the experiment and available in the 
video caption).
The effect of tissue density on device operation is function of the effective density, or tissue density minus 
medium density ρtissue − ρmedium. The only operating aspects that are affected by density require sample move-
ment. Settling wait times and ejection flow rates are directly affected, whereas the minimum device dimension is 
affected due to that value being a crossing point between a Qlift and a Qshear curve. Finally, damaging shear stresses 
are not affected by tissue density. If tissues are too heavy (e.g. 2 g/cm3), it is possible to reach regimes where 
damaging shear stress occurs at lower flow rates than lift regardless of design. However, such high density cells or 
tissues do not exist: for example, single HeLa cells were found to have a density of ~1.043 g/cm3 42.
Ultimately, accurately defining cell life and death or viability within a mathematical model is a challenging 
problem that has yet to be validated experimentally. Thus, this study focuses on establishing the time before cell 
metabolism or proliferation is expected to be affected. With Michaelis-Menten kinetics, this is associated with a 
reduction of cellular uptake of nutrients to half of the maximum value, or a nutrient concentration equal to the 
Michaelis-Menten constant. The time derived from the simulations and plotted in Fig. 4C helps establish a con-
servative replenishment time trep. Following these recommendations ensures that cells throughout the tissue have 
an excess of nutrients at all times without perfusion by renewing cell medium at the interval dictated by trep. In 
practice and since there is a certain time before cells react to nutrient change, it is possible to leave tissues longer 
than the suggested time in this work without significantly affecting cell viability.
To validate theoretical replenishment times trep, the experimental methodology of several publications was 
investigated and compared with the model results. Table 4 compares the experimental trep to the modelled trep for 
various MST designs and tissue sizes. MST designs all fall within the few trapping mechanisms enumerated in 
Fig. 1. Tissue size varies from single cells to large tissue models. The selected publications all use human cancer 
Device operation
Design dimension 
ranges
Optimal 
dimension
Minimum settling time when: 1.2d < w < 6.7d w ≈ 2d
Sample 
ejection 
prior to 
reaching 
τ > 1 Pa
Minimum trap 
width w > 30 μm Any
Trap width 1.1d < w < 3.3d w ≈ 2d
Trap aspect ratio 0.6w < h < 1.1w h ≈ 0.9w
Maximum one sample per trap 
when: w ≤ 1.4d w ≈ 1.4d
Maximum tissue proliferation 
(24 h) when: VM ≥ 100 VT VM ≈ 100 VT
Table 2. Device width w and height h compared to tissue diameter d to optimize device operation.
Volumetric mass density (g/
cm3) 1.01 1.1 2
Settling wait times (s) ≈10 ≈1 ≈0.1
Minimum device dimension 
(μm) ≈10 ≈100 ≈1000
Ejection flow rates (mL/min) ≈0.1 ≈1 ≈10
Shearing flow rates (mL/min) ≈7
Table 3. Comparing device design and operation for specific tissue densities.
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cell lines of various sources (ovarian9, 10, 23, 43, prostate10, breast11, 44, liver7, 18, 44, 45, bone marrow14, colon11, 22, 46 and 
cervical15). The actual nutrient uptake parameters for each specific cancer cell line were not available in the litera-
ture, thus we used the typical values (Table 1) for EMT6/Ro as they provide a complete set of uptake and diffusion 
parameters. If the EMT6/Ro parameters overestimate the actual cell types’, the deduced replenishment times are 
more stringent than necessary.
Out of the 13 reviewed publications we found that 5 employed perfusion, thus automatically satisfying the 
modelled trep and ensuring optimal tissue metabolism; 4 had experimental trep under the modelled trep, ensuring 
optimal tissue metabolism; 3 had experimental trep within 20% of the modelled trep, causing glucose concen-
trations to briefly dip under kM but not causing significant glucose deprivation; one had an experimental trep 
nearly twice the modelled trep, affecting tissue growth rate. The latter (Anada et al.7) is the only publication with 
under-replenished tissues (highlighted in Table 4). As the tissue grows during the experiment reported in the 
publication, replenishment time is reduced from 48 to 24 hours after 6 days of incubation when spheroid size 
exceeds 310 μm. With the 24 hours replenishment time, spheroid growth rate slows down noticeable as tissue size 
passes the optimal VM/VT ratio for 24 hours. With the aforementioned publication’s design and according to the 
model in this work, the maximum spheroid size for a 24 hour replenishment time to optimize cell metabolism 
through the whole spheroid is 487 μm. Exceeding that spheroid size leads to suboptimal cell metabolism in the 
spheroid core and, on a macroscopic scale, a slight reduction in spheroid growth rate.
The lack of under-replenished tissues in the literature is not surprising as tissue growth, and ultimately viabil-
ity, should be affected in this case; biological results of under-replenished experimental methodology would then 
be less appealing for publication. Finally, in some cases where perfusion is used experimentally, Table 4 shows that 
periodical medium replenishment is possible while still keeping nutrient levels high; some require more stringent 
daily replenishment while some permit replenishment times of over 96 hours (4 days). The latter cases would 
benefit from using replenishment methods over bulky, contamination-prone perfusion systems.
Conclusion
The previous analytical and numerical models have shown that optimizing tissue viability in vitro is possible and 
necessary to design effective MSTs. This article presents a complete and systematic analysis of all critical design 
variables of MSTs: trap size, tissue size, trap height and available medium per trap. Before culturing and analysing 
3D tissue models in MSTs, ensuring that the device follows the specific design rules established in this research 
will confirm whether or not device design may affect the viability of samples.
When considering sedimentation, trapping stability and shear stress, the design rules in Table 2 prescribe that 
the best possible practical design is cubic traps at most twice the tissue diameter. When considering bonding to 
or using glass slides, the results show that they significantly impair oxygen transport and may lead larger tissues 
to anoxia. Finally, when considering nutrients that are only supplied through the medium, having a medium 
volume per trap that is at least 100 times the tissue volume with a maximum channel length of 6.4 mm ensures 
maximum metabolism (0th order kinetics) for at least 24 hours. These VM/VT ratio and maximum channel length 
can be tuned to the required channel design and desired replenishment times with equations (6) and (7). All of 
the results are derived for tissues with parameters listed in Table 1.
Trapping 
mechanisms References Cell Lines
Diameter 
of sample 
(μm)
VM
VT
trep (h)
Exp. Model
Resistive
Frimat et al.11 SW580, HT29, MCF-7 17.9* 112 Perfusion 28
Kukhtevich 
et al.14 K562 20* 127 Perfusion 31
Occhetta 
et al.15 HeLa 16* 729 Perfusion 180
Das et al.43,§ TOV112D 250† 138 24 34
Inertial Ota et al.18 HepG2 450† 168 Perfusion 41
Sedimentation
Astolfi et al.10,§ 22Rv1, PC3, TOV112D, OV90 380
‡ 208 48 52
Anada et al.7 HepG2
600† 52 24 13
310† 376 48 93
Patra et al.9
TOV3041G, 
TOV112D, OV90, 
OV866(2)
130† 53 12 13
Patra et al.45,§ HepG2 225† 92 24 23
Open microfluidics
Frey et al.22 HCT-116 eGFP 400† 470 Perfusion 116
Marimuthu 
et al.23,§ OV90 500
† 378 24 92
Grimes et al.46 DLD1 585† 79 24 20
Torisawa 
et al.44 MCF-7, HepG2 260
† 165 48 41
Table 4. Comparing experimental and model replenishment times trep for several publications. *Single cells. 
†Spheroids. ‡Micro-dissected tissue. §Our group.
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The prescribed design rules cover a wide range of devices made of porous materials (e.g. PDMS) with designs 
reducible to the simple MST geometry. These rules are consistent with published experimental studies utilizing 
MSTs. In some cases, perfusion is used where it would not be necessary11, 14, 15. In other cases, it is possible to have 
a slight reduction of viability when a suboptimal VM/VT ratio is chosen7, 10. Ultimately, designs that aim to trap 
single cells or tissues should use nearly cubic traps at most twice the tissue size regardless of the material used 
for fabrication. In the case that the trap is larger, special mechanisms are put in place to ensure a single tissue per 
trap15.
The results presented in this article circumscribe a very specific but extensive set of experiments that will add 
to a better understanding of tissue viability in vitro. Validating these models requires precise knowledge of cell 
parameters: tissue density, cell density, Michaelis-Menten constants, uptake rate and tissue dimensions. These 
parameters can be evaluated experimentally for specific cell types with specialized equipment. The preceding 
design rules will enable designing MSTs as close as possible to optimal operating conditions, thus fabricating 
devices that fully exploit the potential of microfluidics to stably trap-release, and precisely control the in vitro 
tissue microenvironment.
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